To learn more about partnering opportunities with Marina Biotech contact:
June Ameen, Vice President, Corporate Development
jameen@marinabio.com
Hoffmann-La Roche Ltd.
Roche has a non-exclusive license to a portion of Marina Biotech's siRNA technology
Novartis Institutes for BioMedical Research, Inc.
Novartis has a non-exclusive license to Marina
Biotech's DiLA2-based delivery technology
ViThera Laboratories, LLC
Vithera has a sublicense to Marina Biotech's tkRNAi platform for certain non-human applications of tkRNAi including veterinary and agriculture fields